Bryostatin-23

N/A

Report date: 2025/03/14 16:50:14

NME

Base Information

Drug NameBryostatin-23

Drug Alias NameN/A

ClassificationSmall moleculesNatural product/Extract

Mechanisms of ActionAlpha secretases stimulantsProtein kinase C stimulants

TargetsAlpha secretasesProtein kinase C

Therapy Area/IndicationsGlaucomaAlzheimer DiseaseNeuroblastoma +[6]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland ChinaJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesN/A

China Registration ClassN/A

Active Companies +[1] N/A

Inactive CompaniesN/A

Active IndicationsGlaucomaAlzheimer DiseaseNeuroblastoma +[5]

Inactive IndicationsNeoplasms

ATC CodeN/A